Tag: Health Services Pricing

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

All the campaign rhetoric leading up to Election Day 2018 next Tuesday is enough to give you a headache. Maybe that’s one reason why high prescription drug prices have become a major concern among older voters for the midterm elections. “This is a pain point,” said Tim Lash, chief strategy officer of West Health Institute […]

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Research on price variation in healthcare often shows the stark differences patients pay for the same procedure at one hospital compared to another. However, a working paper published by the National Bureau of Economic Research suggests payers play an equally significant role in price variation, even within the same hospital. … For these five procedures, […]

Answering Your Questions about the IPI Drug Pricing Model | HHS

Answering Your Questions about the IPI Drug Pricing Model | HHS

How will this model affect patient access? Could this change my Medicare benefits? The IPI model does not include any restrictions on patient access or choice of drugs. This stands in marked contrast to proposals that would impose formularies in order to negotiate down drug prices. Given the size of the U.S. drug market and […]

The ‘vendors’ in HHS’ new drug pricing plan sound an awful lot like PBMs, experts say  | FierceHealthcare

The ‘vendors’ in HHS’ new drug pricing plan sound an awful lot like PBMs, experts say  | FierceHealthcare

Despite railing against the role of middlemen—namely pharmacy benefit managers—in rising drug prices, the Trump administration appears poised to introduce some of its own into the Part B program. The Department of Health and Human Services unveiled its International Pricing Index (IPI) model last week, which aims to bring down the costs of pharmaceuticals in […]

CLIP of the month: Does orphan drug pricing pose an antitrust problem? | The CLIP Board

CLIP of the month: Does orphan drug pricing pose an antitrust problem? | The CLIP Board

Both the US and EU have therefore sought to incentivise companies to develop orphan drugs. For example, in the US, the Orphan Drugs Act 1983 provides tax credits for clinical research into rare diseases, and the EU’s Horizon 2020 scheme provides funding of around €900 million for collaborative projects related to rare diseases. Although more […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]

Lowering Drug Prices in 3 Easy Pieces | American Council on Science and Health

Lowering Drug Prices in 3 Easy Pieces | American Council on Science and Health

The Trump administration made three proposals last week to influence drug prices, the good, the bad and the ugly. Ending a gag rule on pharmacists is good, the plan to put the “list” price of drugs on those direct to consumer (DTC) pharmaceutical ads is bad, and the consideration of basing US drug prices on […]

Trump adds a global pricing plan to wide attack on drug prices, but doubts persist | Salon

Trump adds a global pricing plan to wide attack on drug prices, but doubts persist | Salon

President Donald Trump’s new pledge to crack down on “the global freeloading” in prescription drugs had a sense of déjà vu. Five months ago, Trump unveiled a blueprint to address prohibitive drug prices, and his administration has been feverishly rolling out ideas ranging from posting drug prices on television ads to changing the rebates that […]

US pricing plan slammed for imposing “foreign price controls” | PMLiVE

US pricing plan slammed for imposing “foreign price controls” | PMLiVE

President Trump’s latest plan to bring down the cost of medicines in the US has drawn fire from the drug industry, which claims it will undermine access to medicines for some of the country’s neediest people. Last week, Trump unveiled proposals to bring US prices for drugs covered by Medicare Part B – which covers […]